Social Experiences and Demographic Factors in the Regulation of Immune Cells
NCT06519487 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2026-05-05
Summary
Immune-mediated inflammatory diseases are a health burden for approximately seven percent of the population of Western nations. Preliminary data suggest variations in ethnic identity and/or geography influence discrimination experiences and inflammatory response trends. This study investigates how geography, ethnicity, and laboratory manipulation of discrimination experiences affect immune cell function and genomic regulation. Flow cytometry and immune cell stimulation will test monocytes collected from peripheral blood for functional effects. Next-generation transcriptomics and epigenomics will assess genomic and epigenetic mechanisms. The hypothesis is that geography, self-identified race, and ethnicity, interacting with laboratory discrimination conditions during the virtual ballgame Cyberball™, significantly affect immune cell function through genomic and epigenetic mechanisms, with perceived discrimination as a moderating factor on the immune outcomes. The transdisciplinary nature of the proposed study aims to provide valuable insights into differential susceptibility to immune-mediated inflammatory diseases across diverse populations. Uncovering these insights will better inform population-relevant interventions for immune-mediated inflammatory diseases.
Conditions
- Perceived Discrimination
- RNA
- Inflammatory Response
Interventions
- BEHAVIORAL
-
Cyberball
Cyberball™ is a virtual social exclusion game that simulates social interactions and acute discrimination experiences in a controlled laboratory setting. The game involves passing a virtual ball between players represented by images. In this study, only the participant is a real player, while the other "players" are pre-programmed virtual avatars controlled by the experimenter using Cyberball software. The ethnicity of these virtual players can be manipulated by changing the stock photos used to represent them. Participants in the Race-Based Social Exclusion condition play Cyberball with virtual players who appear to be of a different ethnicity from the participant. In the Non-Race-Based Social Exclusion, the participant plays with virtual players who do not have any obvious ethnic differences from the participant, and social inclusion is a washout condition where the participant receives the ball from the virtual players, regardless of the ethnicity of the avatars.
Sponsors & Collaborators
-
Texas Christian University
collaborator OTHER -
University of Maryland, Baltimore
collaborator OTHER -
University of Baltimore
collaborator UNKNOWN -
Morgan State University
lead OTHER
Principal Investigators
-
Ingrid K Tulloch, PhD · Morgan State University
-
Sarah E Hill, PhD · Texas Christian University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-27
- Primary Completion
- 2028-06-03
- Completion
- 2028-06-03
Countries
- United States
Study Locations
More Related Trials
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING
-
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
NCT05682625 ·Status: WITHDRAWN
-
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
NCT04408950 ·Status: COMPLETED
-
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
NCT00001582 ·Status: COMPLETED
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
NCT04858607 ·Status: COMPLETED
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
T Cells Response to SARS COV 2 Peptides
NCT04573348 ·Status: UNKNOWN
-
Immune Cell Response to Stimuli
NCT00397280 ·Status: RECRUITING
-
Thymic Function in Patients With COVID-19
NCT04716907 ·Status: COMPLETED
-
The Role of the Thymus in Type I Diabetes.
NCT03236558 ·Status: WITHDRAWN ·Phase: NA
-
Distribution of Immune Cells Subsets in Healthy Females
NCT05609799 ·Status: COMPLETED ·Phase: NA
-
Immune Response to the COVID-19 Vaccine
NCT04936997 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigating The Experiences of Patients In Immunotherapy Clinical Trials
NCT05435365 ·Status: NOT_YET_RECRUITING
-
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
NCT00001603 ·Status: COMPLETED
-
Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells. PLASMACYTOKID
NCT02956980 ·Status: TERMINATED ·Phase: NA
-
Human Immunome Program
NCT03118687 ·Status: COMPLETED
-
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
NCT01967238 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Sequencing T-cells in Type I Diabetes Mellitus
NCT02040337 ·Status: COMPLETED
-
Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations
NCT06027229 ·Status: COMPLETED ·Phase: PHASE2
-
Immuno-Oncology Database and Bioregistry
NCT04656873 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Modulation by Exosomes in COVID-19
NCT05191381 ·Status: RECRUITING
-
Vaccine-induced Immunity in Immunocompromised Patients
NCT06612515 ·Status: RECRUITING
-
Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers
NCT01281995 ·Status: COMPLETED
-
Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.
NCT06300853 ·Status: RECRUITING ·Phase: NA